Gannet BioChem Acquires Laysan Bio

January 22, 2026

Gannet BioChem, a PE-backed specialty CDMO, has acquired Laysan Bio, a maker of activated polyethylene glycol (PEG) reagents based in Arab, Alabama. The add-on expands Gannet BioChem's activated polymer and bioconjugation capabilities, strengthening its ability to support partners from early development through GMP manufacturing.

Buyers
Gannet BioChem, Ampersand Capital Partners
Targets
Laysan Bio
Platforms
Gannet BioChem
Industry
Biotechnology
Location
Alabama, United States
Transaction Type
Addon

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.